Ijaz M K, Dent D, Haines D, Babiuk L A
Veterinary Infectious Disease Organization, University of Saskatchewan, Saskatoon, Canada.
Exp Mol Pathol. 1989 Oct;51(2):186-204. doi: 10.1016/0014-4800(89)90019-1.
A murine model to study enteritis induced by bovine (BRV) and murine rotavirus (MRV) has been developed. The course of infection was determined by clinical symptoms of diarrhea and virus isolation as well as histopathological, immunohistochemical, and electron microscopic methods. Both isolates were able to replicate and produce clinical symptoms in neonatal mice. Rotavirus-free neonates were orally inoculated with MRV or BRV and observed over a 192-hr postinoculation (HPI) period. Following infection with 10(4) PFU of virus, diarrhea and maximal intestinal dysfunction, as measured by xylose absorption, did not occur until beyond 20 hr postinfection even though maximal virus production occurred at 10-15 HPI. Immunohistochemically and by electron microscopy we were able to demonstrate viral antigen and virus particles in the enterocytes of villous tips at 5-8 HPI. The appearance of diarrheal symptoms was dependent on the virus dose and the type of virus isolate inoculated. The disease could be induced with doses as low as 1 x 10(2) PFU/mouse of BRV and 1 x 10(1) PFU/mouse of MRV. On the basis of these results, MRV was found to be more virulent than BRV in this model. The model should prove useful for studies designed to assess rotavirus virulence genes and for vaccine protection studies. This work emphasizes the need for early sample collection for critical evaluation of any vaccine or antiviral agent using this model.
已建立一种用于研究牛轮状病毒(BRV)和鼠轮状病毒(MRV)诱导的肠炎的小鼠模型。通过腹泻的临床症状、病毒分离以及组织病理学、免疫组织化学和电子显微镜方法来确定感染过程。两种分离株都能够在新生小鼠中复制并产生临床症状。将无轮状病毒的新生小鼠口服接种MRV或BRV,并在接种后192小时(HPI)内进行观察。在用10⁴ PFU病毒感染后,即使在感染后10 - 15小时达到最大病毒产量,但直到感染后20小时以后才出现腹泻和通过木糖吸收测量的最大肠道功能障碍。通过免疫组织化学和电子显微镜,我们能够在感染后5 - 8小时在绒毛顶端的肠细胞中证明病毒抗原和病毒颗粒。腹泻症状的出现取决于病毒剂量和接种的病毒分离株类型。用低至1×10² PFU/小鼠的BRV和1×10¹ PFU/小鼠的MRV剂量即可诱发疾病。基于这些结果,在该模型中发现MRV比BRV更具致病性。该模型对于旨在评估轮状病毒毒力基因的研究以及疫苗保护研究应该是有用的。这项工作强调了在使用该模型对任何疫苗或抗病毒药物进行关键评估时尽早采集样本的必要性。